Adan Medical develops a digital platform that integrates telemonitoring and data analytics to enhance the management of anaphylaxis, ensuring that patients have access to adrenaline autoinjectors in optimal condition. The solution addresses the rising prevalence of severe allergic reactions by improving adherence to treatment protocols and providing real-time stock management for healthcare providers.
Funding
Funding not disclosed
Founders
Product
Problem
Anaphylaxis, a severe and potentially fatal allergic reaction, is increasing in prevalence, especially among children and young adults. Delayed access to epinephrine auto-injectors and inadequate adherence to treatment protocols contribute to preventable deaths and reduced quality of life for allergy sufferers.
Solution
Adan Medical Innovation develops and distributes an integrated digital platform designed to improve the management of anaphylaxis. The company's "Alergoprotección" solution includes the Allergobox, a smart cabinet for public spaces containing epinephrine auto-injectors, and a companion mobile app for patients. The Allergobox features a video tutorial to guide users through the injection process, along with temperature and expiration date monitoring to ensure the epinephrine is always in optimal condition. The mobile app provides users with a symptom checker, a map of nearby Allergobox locations, and direct connection to emergency services. Adan Medical also offers a telecontrol platform for B2B clients, enabling remote stock management and prevalence tracking.
Target Audience
The primary target audience includes individuals at risk of anaphylaxis, their families, public spaces such as schools and restaurants, and healthcare providers seeking to improve patient outcomes and stock management.
Features
- Allergobox: Smart cabinet containing two adult and two pediatric epinephrine auto-injectors for public spaces.
- Instructional video on the Allergobox screen to guide users through the epinephrine injection process.
- Temperature monitoring within the Allergobox to ensure optimal storage conditions.
- Expiration date tracking with alerts for timely replacement of auto-injectors.
- Remote monitoring and management of Allergobox units via a centralized platform.
- Mobile app: Symptom checker to help users identify potential anaphylactic reactions.
- Mobile app: Map displaying nearby Allergobox locations, pharmacies, and hospitals.
- Mobile app: Emergency contact activation with location sharing.
- Telecontrol platform: Stock level monitoring and prevalence data analysis for B2B clients.
- NBIOT technology for reliable connectivity and remote management.